Response criteria for phase II studies of supratentorial malignant glioma.

Keywords

Medicine, Glioma, Complete response, Magnetic resonance imaging, Progressive disease

References

• Absence of contrast enhancement on CT brain scans of patients with supratentorial malignant gliomasMarc C. Chamberlain, Judith A. Murovic, Victor A. Levin — 1988
• Steroid‐induced CT changes in patients with recurrent malignant gliomaJ. Gregory Cairncross, David R. Macdonald, J. H. Warwick Pexman — 1988
• Criteria for termination of phase II chemotherapy for patients with progressive or recurrent brain tumorH. S. Friedman, S. Clifford Schold, W T Djang — 1989
• Computerized tomography in the prognosis of malignant cerebral gliomas.Judith A. Murovic, Krzysztof Turowski, Charles B. Wilson — 1986
• The accuracy of volumetric measurement of high-grade gliomas.R. Chisholm, Sally Stenning, T.D. Hawkins — 1989
• Successful chemotherapy for recurrent malignant oligodendrogliomaJ. Gregory Cairncross, D R Macdonald — 1988
• Criteria and definitions for response and relapse in children with brain tumorsPaul M. Zeltzer, Henry S. Friedman, Donald G. Norris — 1985
• Criteria for evaluating patients undergoing chemotherapy for malignant brain tumors.Victor A. Levin, David C. Crafts, David Norman — 1977
• Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management.Antonella Surbone, D L Longo, V T DeVita — 1988
• Influence of measurement error on assessment of response to anticancer chemotherapy: proposal for new criteria of tumor response.David Warr, Steven McKinney, Ian F. Tannock — 1984
• Post-Surgical Contrast Enhancement Mimicking Residual Brain TumourJ. Gregory Cairncross, J. H. Warwick Pexman, Michel P. Rathbone — 1985

Cited by

• Fotemustine Combined with Procarbazine in Recurrent Malignant Gliomas: A Phase I Study with Evaluation of Lymphocyte O6-alkylguanine–DNA Alkyltransferase ActivityA. Boiardi, Antonio Silvani, Emilio Ciusani — 2001
• Survival in patients with recurrent glioma as a measure of treatment efficacy: prognostic factors following nitrosourea chemotherapy.範惇 松井, 幸生 池本 — 1994
• Specific genetic predictors of chemotherapeutic response and survival in patients with anaplastic oligodendrogliomas.Mindy S. Hamilton — 1998
• Procarbazine and high-dose tamoxifen as a second-line regimen in recurrent high-grade gliomas: a phase II study.Marguerite Roza, Jon Fullerton — 1999
• Mechanisms of action and potential therapeutic uses of thalidomide.Hamza Mujagić, Bruce A. Chabner, Zlata Mujagić — 2002
• Thalidomide as an Anti-angiogenic Agent in Relapsed GliomasPablo Martín de Santa Olalla Saludes — 2004
• Radiotherapy for brain metastases: defining palliative response.Andrea Bezjak, Janice Adam, Tony Panzarella — 2001
• Temozolomide in Glioblastoma Multiforme of the ElderlyKhalid Alssardiyah — 2002
• Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression.Jaume Colomer — 2003
• Phase I study of temozolomide and escalating doses of oral etoposide for adults with recurrent malignant gliomaJin Zou, Xiaozhou Liao, D. J. H. Cockayne — 2003
• Gliomatosis cerebri順平 前田, 亮一 新熊, 達郎 高橋 — 2004
• Phase I/pharmacokinetic study of CCI-779 in patients with recurrent malignant glioma on enzyme-inducing antiepileptic drugsXabier Pikaza Ibarrondo — 2004
• Primary central nervous system lymphomas (PCNSL): MRI response criteria revisedUwe Schlegel, A Jürgens, Hendrik Pels — 2005
• Phase II Study of Temozolomide and Concomitant Whole-Brain Radiotherapy in Patients with Brain Metastases from Solid Tumors茂 井上, 輝一 下光, 信男 吉池 — 2007
• Efficacy and tolerability of temozolomide in an alternating weekly regimen in patients with recurrent glioma.Antje Wick, Jörg Felsberg, Joachim P. Steinbach — 2007
• Kriterien für die radiologische Beurteilung des TherapieansprechensMelvin D’Anastasi, Nicolai Schramm, Maximilian F. Reiser — 2013
• Advances in neuroimaging techniques for the evaluation of tumor growth, vascular permeability, and angiogenesis in gliomasJ. Terazono, Nao Asada, H. Demura — 2008
• Phase II Study of Combination Taxol and Estramustine Phosphate in the Treatment of Recurrent Glioblastoma MultiformeMark Rosenthal, Michael L. Gruber, Jon Glass — 2000
• Bidimensional measurements in brain tumors: assessment of interobserver variability.José Rico Irles — 2009
• Parametric response map as an imaging biomarker to distinguish progression from pseudoprogression in high-grade glioma.Jean Bowen, Marianne Hawkins, Carol King — 2010

Related papers

• Tracheal rupture in a cat: diagnosis by computed tomography.Jitender Bhandal, Alan B. Kuzma — 2008
• Transarterial chemoembolization for hepatocellular carcinoma with drug-eluting microspheresWaleed M. Hetta, Naglaa Shebria — 2014
• Clinical Outcomes of Mixed Response to Pembrolizumab in Advanced Urothelial Carcinoma After Platinum-based ChemotherapyNobuki Furubayashi, Takahito Negishi, Naotaka Sakamoto — 2021
• cis-Platinum in gynecologic cancer. I. Epithelial ovarian cancer.Don Hall, Robert B. Diasio, Dean R. Goplerud — 1981
• [Combined administration of futraful and esquinone for the treatment of advanced ovarian cancer].Seiya Inoue, Osamu Fukuda, C Tajima — 1982
• Efficacy of Temozolomide in Treatment of Recurrent GliomaZhaoxia Deng — 2010
• Low-dose radiotherapy in indolent lymphoma.Christine Rossier, Ulrike Schick, Raymond Miralbell — 2011
• Role of percutaneous ethanol ablation in malignant liver tumoursSatnam Singh, Jagjeet Singh, Pankaj Dugg — 2016
• cis-Platinum in gynecologic cancer. II. Squamous cell carcinoma of the cervix.Don Hall, Robert B. Diasio, Dean R. Goplerud — 1981